Immune checkpoint inhibitor-related pneumonitis with atypical radiologic features in a patient with anti-aminoacyl-tRNA synthetase antibody-Reference-Cited by-同舟云学术

Immune checkpoint inhibitor-related pneumonitis with atypical radiologic features in a patient with anti-aminoacyl-tRNA synthetase antibody

Published:2023 Issue: Volume:41 Page:101797
ISSN:2213-0071
Container-title:Respiratory Medicine Case Reports
language:en
Short-container-title:Respiratory Medicine Case Reports

Author:

Ichihara Seiya,Ogino Hirokazu,Yoneda Hiroto,Haji Keiko,Kagawa Kozo,Murakami Kojin,Mima Masato,Aoi Yu,Mitsuhashi Atsushi,Tsukazaki Yuki,Yabuki Yohei,Ozaki Ryohiko,Sato Seidai,Nokihara Hiroshi,Nishioka Yasuhiko

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference20 articles.

1. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial;West;Lancet Oncol.,2019

2. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer;Gandhi;N. Engl. J. Med.,2018

3. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer;Paz-Ares;N. Engl. J. Med.,2018

4. Immune-related adverse events associated with immune checkpoint blockade;Postow;N. Engl. J. Med.,2018

5. PD-1 inhibitor-related pneumonitis in advanced cancer patients: radiographic patterns and clinical course;Nishino;Clin. Cancer Res.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-asparaginyl-tRNA synthetase antibody-positive pneumonitis in a patient with immune checkpoint inhibitor treatment: A case report and literature review;Modern Rheumatology Case Reports;2024-08-05

2. Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management;Frontiers in Immunology;2024-02-15

3. Atezolizumab;Reactions Weekly;2023-11-18